MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2019 International Congress

    Longstanding cervical dystonia followed by parkinsonism – coincidence, risk factor or syndromic association?

    B. Balint, F. Gövert, A. Latorre, E. Mulroy, R. Erro, A. Batla, T. Warner, K. Bhatia (London, United Kingdom)

    Objective: To describe the occurence of parkinsonism after longstanding dystonia in a cohort of patients followed for long periods in our botulinum toxin injection clinic.…
  • 2019 International Congress

    RDP is associated with bulbar and limb weakness: broadening the phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP)

    I. Haq, B. Snively, J. Cook, C. Suerken, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)

    Objective: To describe a new finding of weakness associated with RDP. Background: RDP is caused by mutations of the ATP1A3 gene. The phenotype of RDP…
  • 2019 International Congress

    Stiff Limb Syndrome Masquerading As a Focal Limb Dystonia

    P. Morrison, R. Barbano (Rochester, NY, USA)

    Objective: To report a case of immune-mediated stiff limb syndrome referred for extremity focal dystonia. Background: Autoantibodies to glutamic acid decarboxylase (GAD) are associated with…
  • 2019 International Congress

    After-effects Of Transcranial direct current stimulation (tDCS) On Hand Biomechanics In A Patient With Secondary Dystonia

    F. Yadolahi, M. Abedi (Tehran, Islamic Republic of Iran)

    Objective: The purpose of this study was to identify differences in kinematic arm motion after tDCS intervention based on principal component analysis that allows generating…
  • 2019 International Congress

    The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

    M. Kurian, V. Leuzzi, K. Peall, R. Pons, R. Dale, E. de Grandis, S. Yilmaz, J. Cobben, R. Guerrini, E. Sheridan, P. Vieira, J. Uusimaa, P. Munot, F. Muntoni, M. Smith, S. Mohammed, E. Meyer, J. Ng, A. Papandreou, H. Baide, F. Danti, A. Macaya, J. Ortigoza, K. Gorman, B. Perez Duenas (Barcelona, Spain)

    Objective: To better delineate the genetic landscape and key clinical characteristics that define complex early onset monogenic hyperkinetic movement disorders (HMD). Background: Hyperkinetic movement disorders…
  • 2019 International Congress

    Quantitative assessments better delineate rare disease: reconsidering the diagnostic criteria in ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP)

    I. Haq, B. Snively, K. Sweadner, C. Suerken, J. Cook, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)

    Objective: To revise diagnostic criteria for RDP based on a cohort of ATP1A3 mutation+ individuals. Background: RDP is caused by mutations of the ATP1A3 gene.…
  • 2019 International Congress

    Depression and anxiety in cervical dystonia

    M. Munteanu (Bucharest, Romania)

    Objective: We had proposed to evaluate appearance of anxiety and depression in patients with cervical dystonia(CD) and influence of disease on the quality of life.…
  • 2019 International Congress

    Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients

    A. Yoo, S. Bobker, S. Broner, A. Lee, G. Auerbach, L. Klebanoff, M. Vo, H. Sarva (New York, NY, USA)

    Objective: To describe dystonia phenomenology and preliminary pain response to toxin therapy in a single-center migraine cohort. Background: The co-existence of headache and craniocervical dystonia…
  • 2019 International Congress

    Phenotypic variability and extreme age of presentation of GCH1 gene mutation in dopa-responsive dystonia

    F. Abu Ahmad, P. Ponger, M. Rotstein, A. Migirov Sandrovitz, N. Giladi, A. Orr-Urtreger, T. Gurevich, S. Ben-Shachar (Tel Aviv, Israel)

    Objective: To highlight the wide phenotypical variability among GCH1 gene mutation carriers and the importance of molecular work-up and establishing genotype-phenotype correlations in GCH1 related…
  • 2019 International Congress

    Clinical and genetic characteristics of a new mutation causing Segawa´s disease in a Spanish kindred

    J. Hernández-Vara, S. Lucas (Barcelona, Spain)

    Objective: To describe the clinical phenotype and genetic characteristics of a novel mutation causing Segawa´s disease in a Spanish family. Background: Dopa-Responsive Dystonia (DRD) is…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley